https://en.regulatory-j.com/submission-of-documents-in-english/ 2024-09-23T17:33:19+00:00 monthly 0.2 https://en.regulatory-j.com/definition-of-new-drug-in-japan/ 2024-09-16T20:56:46+00:00 monthly 0.2 https://en.regulatory-j.com/us-approves-self-administered-influenza-vaccine/ 2024-09-22T19:59:38+00:00 monthly 0.2 https://en.regulatory-j.com/timing-of-new-drug-approvals-from-2025/ 2024-11-09T15:50:49+00:00 monthly 0.2 https://en.regulatory-j.com/akuugo-drug-committee-june-2024/ 2024-09-23T22:24:18+00:00 monthly 0.2 https://en.regulatory-j.com/pmda-consultations-and-pre-consultation-meetings/ 2024-09-28T22:32:02+00:00 monthly 0.2 https://en.regulatory-j.com/roles-of-mhlw-pmda/ 2024-09-29T08:04:56+00:00 monthly 0.2 https://en.regulatory-j.com/period-new-drug-application-price-listing/ 2024-09-29T08:29:53+00:00 monthly 0.2 https://en.regulatory-j.com/drugs-pilot-of-moderate-risk-change/ 2024-09-30T23:10:07+00:00 monthly 0.2 https://en.regulatory-j.com/japanese-website-basics-of-medical-program-development/ 2024-10-01T18:37:56+00:00 monthly 0.2 https://en.regulatory-j.com/notification-of-use-results-survey/ 2024-10-04T21:30:35+00:00 monthly 0.2 https://en.regulatory-j.com/gate-opening-summit-july-30-2024/ 2024-10-06T09:14:41+00:00 monthly 0.2 https://en.regulatory-j.com/overview-of-japanese-phase-i-trials/ 2024-10-07T19:51:12+00:00 monthly 0.2 https://en.regulatory-j.com/notification-of-necessity-for-japanese-data/ 2024-11-10T20:08:03+00:00 monthly 0.2